JPH04267895A - Simple method for detecting dna product amplified by polymerase chain reaction(pcr) - Google Patents

Simple method for detecting dna product amplified by polymerase chain reaction(pcr)

Info

Publication number
JPH04267895A
JPH04267895A JP2647791A JP2647791A JPH04267895A JP H04267895 A JPH04267895 A JP H04267895A JP 2647791 A JP2647791 A JP 2647791A JP 2647791 A JP2647791 A JP 2647791A JP H04267895 A JPH04267895 A JP H04267895A
Authority
JP
Japan
Prior art keywords
dna
pcr
product
polymerase chain
chain reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2647791A
Other languages
Japanese (ja)
Inventor
Kiichi Sawai
喜一 澤井
Masatsune Kurono
昌庸 黒野
Takahiko Mitani
隆彦 三谷
Takahito Shiromori
孝仁 城森
Haruo Takahashi
治雄 高橋
Yuji Hayashi
林 祐 二
Eiji Suzuki
栄二 鈴木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanwa Kagaku Kenkyusho Co Ltd
Original Assignee
Sanwa Kagaku Kenkyusho Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanwa Kagaku Kenkyusho Co Ltd filed Critical Sanwa Kagaku Kenkyusho Co Ltd
Priority to JP2647791A priority Critical patent/JPH04267895A/en
Priority to EP91120311A priority patent/EP0488243A1/en
Publication of JPH04267895A publication Critical patent/JPH04267895A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To enable high-sensitivity detection of a DNA product for the clinical examination capable of extremely easily treating a number of specimens in a short time by amplifying a DNA product by polymerase chain reaction(PCR) and reacting the amplified product with a fluorescent substance having affinity to DNA. CONSTITUTION:The objective DNA to be detected (e.g. human hepatitis C virus DNA) is amplified by a polymerase chain reaction(PCR) comprising the repeated DNA synthesis reaction with a DNA polymerase using two kinds of primers holding the DNA region therebetween. The amplified objective DNA product is added and reacted to a solution produced by dissolving a fluorescent substance having affinity to DNA (e.g. mithramycin) in 300mM aqueous solution of magnesium chloride. The intensity of the fluorescence is measured at an excitation wavelength of 440nm and a detection wavelength of 540nm to easily detect the objective DNA product in high sensitivity.

Description

【発明の詳細な説明】[Detailed description of the invention]

【0001】0001

【産業上の利用分野】本発明はポリメラーゼ連鎖反応(
PCR)で増幅したDNA産物の簡便な検出方法に係る
[Industrial Application Field] The present invention relates to polymerase chain reaction (
This invention relates to a simple method for detecting DNA products amplified by PCR.

【0002】0002

【従来技術】ポリメラーゼ連鎖反応(PCR)は、目的
とするDNA領域をはさむ2種のブライマーを用いてD
NAポリメラーゼによるDNA合成反応を繰り返すこと
によってその目的のDNA断片を100万倍以上に増幅
させる方法である。従ってPCR法は、原理的には1コ
ピーのDNAでも増幅可能な高感度検出法であるのでウ
イルスの検出、癌の診断、遺伝病の診断等の臨床面での
診断応用が期待されている。
[Prior Art] Polymerase chain reaction (PCR) uses two types of primers that sandwich a DNA region of interest.
This is a method in which the desired DNA fragment is amplified one million times or more by repeating the DNA synthesis reaction using NA polymerase. Therefore, since the PCR method is in principle a highly sensitive detection method that can amplify even one copy of DNA, it is expected to be applied to clinical diagnostics such as virus detection, cancer diagnosis, and genetic disease diagnosis.

【0003】しかしながらそのPCR反応産物の検出に
おいては、一般にアガロースまたはポリアクリルアミド
電気泳動とそれに続くエチジウムプロミド染色さらには
UV照射による反応産物の観察と写真撮影を行う必要が
ある。この方法は操作が煩雑で処理検体の数も限られ時
間もかかることから、一般の病院や臨床検査室では使用
が困難な状況である。従って、PCR法による診断法は
、有用性が高いにかかわらず、その反応産物の検出法が
障害となって一般に普及していないのが現状である。
However, detection of the PCR reaction product generally requires agarose or polyacrylamide electrophoresis followed by ethidium bromide staining, as well as observation and photography of the reaction product by UV irradiation. This method is difficult to operate, requires a limited number of samples to be processed, and is time-consuming, making it difficult to use in general hospitals and clinical laboratories. Therefore, although the diagnostic method using PCR method is highly useful, the current situation is that the method for detecting the reaction product is an obstacle and is not widely used.

【0004】0004

【発明が解決しょうとする課題及び発明の目的】慣用の
技術によれば、PCR法による反応産物を、簡便であり
かつ多検体を一度に処理できる検出法はいまだ確立され
るに至っていない。
[Problems to be Solved by the Invention and Objects of the Invention] According to conventional techniques, a simple detection method for PCR reaction products that can process multiple samples at once has not yet been established.

【0005】本発明は従来技術におけるこのような困難
をふまえてなされたものであり、本発明の主たる目的は
、PCR法で増殖したDNA産物の検出において、簡便
で短時間の内に多検体を一度に処理できる方法を提供す
る事にある。
[0005] The present invention has been made in view of these difficulties in the prior art, and the main purpose of the present invention is to easily and quickly detect a large number of samples in the detection of DNA products propagated by the PCR method. The purpose is to provide a method that can be processed all at once.

【0006】[0006]

【課題を解決し、目的を達成する手段及び作用】本発明
は、PCR反応産物の検出法についての鋭意検討を行っ
た結果、DNAに親和性を有する蛍光物質を用いれば、
PCR反応産物と蛍光物質が結合し、その結果生じた螢
光を測定することにより、その反応物を簡単に検出でき
ることを見出し、これにより従来技術の課題を解決し上
記の目的を達成するに至った。本発明による検出法にお
いて、PCR反応産物のDNAは、生物、ウイルス、プ
ラスミド及び遺伝子組換体由来のDNAもしくはRNA
を鋳型としたものである事ができ、DNAに親和性を有
する螢光物質としては、抗生物質、核染色色素及び抗癌
剤等を用いる事ができる。これらの螢光物質としては、
例えばミトラマイシン、アクリジンオレンジ、エチジウ
ムブロマイド、4´、6´ージアミジノー2ーフェニル
インドール、キナクリンマスタード等が使用できる。特
にDNAに親和性を有する螢光物質においてはミトラマ
イシン、エチジウムブロミドが有効である。
[Means and effects for solving the problems and achieving the objects] As a result of extensive research into methods for detecting PCR reaction products, the present invention has revealed that if a fluorescent substance that has an affinity for DNA is used,
We have discovered that the reaction product can be easily detected by combining a PCR reaction product with a fluorescent substance and measuring the resulting fluorescence, thereby solving the problems of the prior art and achieving the above objectives. Ta. In the detection method according to the present invention, the DNA of the PCR reaction product is DNA or RNA derived from organisms, viruses, plasmids, and genetic recombinants.
can be used as a template, and antibiotics, nuclear staining dyes, anticancer drugs, etc. can be used as fluorescent substances that have affinity for DNA. These fluorescent substances include:
For example, mithramycin, acridine orange, ethidium bromide, 4',6'-diamidino-2-phenylindole, quinacrine mustard, etc. can be used. In particular, mithramycin and ethidium bromide are effective for fluorescent substances that have an affinity for DNA.

【0007】以下には実施例をあげ本発明を更に詳細に
説明する。なお、本発明実施例はミトラマイシンとエチ
ジウムブロミドを用いた方法を開示するものであるが、
DNAに親和性を有する螢光物質であれば同様にしてP
CR産物を検出する事ができ本発明は実施例に限定され
るものではない。
[0007] The present invention will be explained in more detail below with reference to Examples. In addition, although the present invention example discloses a method using mithramycin and ethidium bromide,
If it is a fluorescent substance that has an affinity for DNA, P
CR products can be detected, and the present invention is not limited to the examples.

【0008】[0008]

【実施例】(1)ミトラマイシンによるPCR産物の検
出例 ヒトC型肝炎ウイルス(HCV)のPCRによるPCR
産物の検出例を基に説明する。2組のHCV特異的なプ
ライマーを用い、C型肝炎患者と正常人の血清でそれぞ
れ連続して2回のPCRを行った。この時得られたPC
R産物をポリアクリルアミドゲル電気泳動により確認し
た結果を図1に示した。図1に見られるようにC型肝炎
患者の血清では予測された180塩基対の位置にバンド
が確認された。一方正常人の血清では全くバンドは検出
されなかった。この2つの検体を用いて以下の螢光物質
による反応を行った。
[Example] (1) Example of detection of PCR product using mithramycin PCR using human hepatitis C virus (HCV) PCR
This will be explained based on an example of product detection. Using two sets of HCV-specific primers, PCR was performed twice consecutively using serum from a hepatitis C patient and a normal person. The PC obtained at this time
The results of confirming the R product by polyacrylamide gel electrophoresis are shown in FIG. As shown in FIG. 1, a band was confirmed at the predicted 180 base pair position in the serum of a hepatitis C patient. On the other hand, no band was detected in serum from normal subjects. Using these two specimens, the following reaction with a fluorescent substance was performed.

【0009】上記のPCR反応液20μlに、蒸留水3
70μlと300mMの塩化マグネシウム溶液に溶解し
た200μg/mlのミトラマイシンを10μl加えた
後、励起波長440nm、検出波長540nmにて螢光
強度を測定した。その結果を表1に示した。
[0009] To 20 μl of the above PCR reaction solution, add 3 mL of distilled water.
After adding 10 μl of 200 μg/ml mithramycin dissolved in 70 μl and 300 mM magnesium chloride solution, the fluorescence intensity was measured at an excitation wavelength of 440 nm and a detection wavelength of 540 nm. The results are shown in Table 1.

【0010】表  1  ミトラマイシンによるPCR
反応産物の検出                          
                         
螢光強度                     
                         
                         
           HCV患者血清(PCR陽性)
        1.5±0.2          
          正常人血清(PCR陰性)   
         0.4±0.1         
           ブランク(プライマーのみ) 
         0.4±0.1        こ
こでPCR陽性は陰性の螢光強度の約3〜4倍であり、
このことからブランクの螢光強度をカットオフ値に設定
するればそれ以上の螢光強度を示すものはPCR産物を
含んでいると判断できる。
Table 1 PCR with mithramycin
Detection of reaction products

Fluorescence intensity


HCV patient serum (PCR positive)
1.5±0.2
Normal human serum (PCR negative)
0.4±0.1
Blank (primer only)
0.4±0.1 Here, PCR positivity is about 3 to 4 times the fluorescent intensity of negative,
From this, if the blank fluorescence intensity is set as a cutoff value, it can be determined that anything exhibiting a fluorescence intensity higher than this value contains a PCR product.

【0011】(2)エチジウムブロミドによるPCR産
物の検出例 図1に示した2つのPCR反応陽性および陰性検体を用
いて測定を行った。上記のPCR反応液20μlに、蒸
留水370μlと、蒸留水に溶解した20μl/mlの
濃度のエチジウムブロミド溶液を10μl加えた後、励
起波長260nm、検出波長450nmにて螢光強度を
測定した。その結果を表2に示した。
(2) Example of Detection of PCR Products Using Ethidium Bromide Measurements were carried out using the two PCR reaction positive and negative samples shown in FIG. After adding 370 μl of distilled water and 10 μl of an ethidium bromide solution dissolved in distilled water at a concentration of 20 μl/ml to 20 μl of the above PCR reaction solution, the fluorescence intensity was measured at an excitation wavelength of 260 nm and a detection wavelength of 450 nm. The results are shown in Table 2.

【0012】表  2  エチジウムブロミドによるP
CR産物の検出                          
                         
螢光強度                     
                         
                         
             HCV患者血清(PCR陽
性)      12.1±1.3         
           正常人血清(PCR陰性)  
          5.7±0.8        
            ブランク(プライマーのみ)
          5.4±0.5      ここ
でPCR陽性は陰性の螢光強度の約2倍であり、このこ
とからブランクの螢光強度をカットオフ値に設定すれば
それ以上の螢光強度を示すものはPCR産物を含んでい
ると判断できる。
Table 2 P by ethidium bromide
Detection of CR products

Fluorescence intensity


HCV patient serum (PCR positive) 12.1±1.3
Normal human serum (PCR negative)
5.7±0.8
Blank (primer only)
5.4±0.5 Here, PCR positivity is approximately twice the fluorescence intensity of negative PCR, so if the blank fluorescence intensity is set as the cutoff value, anything showing a higher fluorescence intensity will be detected. It can be determined that it contains a PCR product.

【0013】[0013]

【発明の効果】本発明のPCR産物検出法によれば、従
来の電気泳動、エチジウムブロミド染色、UV照射によ
る反応産物の確認及び写真撮影などの操作を全く必要と
しない。従ってPCR反応産物の検出に際しては、当該
試料とDNAに親和性を有する螢光物質を混ぜ合わせ、
DNA産物により特異的に生ずる螢光を測定するだけで
完了するので、操作の簡素化がもたらされると共に、測
定時間の大幅な短縮ができる。さらに本発明法により多
量の検体を一度に処理できる事が可能になり、簡便であ
るがために検出の自動化ないし半自動化が可能である。
According to the PCR product detection method of the present invention, conventional operations such as electrophoresis, ethidium bromide staining, confirmation of reaction products by UV irradiation, and photography are not required at all. Therefore, when detecting PCR reaction products, the sample is mixed with a fluorescent substance that has an affinity for DNA.
Since the measurement is completed simply by measuring the fluorescence specifically produced by the DNA product, the operation is simplified and the measurement time can be significantly shortened. Furthermore, the method of the present invention makes it possible to process a large amount of specimen at once, and because it is simple, automatic or semi-automated detection is possible.

【図面の簡単な説明】[Brief explanation of the drawing]

【図  1】図1は本発明に用いた、ヒトC型肝炎ウイ
ルスのPCR産物のポリアクリルアミドゲル電気泳動を
示した図である。
FIG. 1 is a diagram showing polyacrylamide gel electrophoresis of a PCR product of human hepatitis C virus used in the present invention.

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】ポリメラーゼ連鎖反応(PCR)で増幅し
た産物をDNAに親和性を有する蛍光物質と反応させる
ことを特徴とするDNAの簡便な検出法。
1. A simple method for detecting DNA, which comprises reacting a product amplified by polymerase chain reaction (PCR) with a fluorescent substance that has an affinity for DNA.
【請求項2】ポリメラーゼ連鎖反応(PCR)で増幅し
た産物(DNA)が生物、ウイルス、プラスミド及び遺
伝子組換体由来のDNAもしくはRNAを鋳型としたも
のであることを特徴とする、請求項(1)に記載のDN
Aの簡便な検出法。
Claim 2: Claim (1) characterized in that the product (DNA) amplified by polymerase chain reaction (PCR) uses DNA or RNA derived from an organism, virus, plasmid, or genetic recombinant as a template. ) DN
A simple detection method for A.
【請求項3】DNAに親和性を示す蛍光物質が抗生物質
、核染色用色素および抗癌剤であることを特徴とする請
求項(1)または(2)記載のDNAの簡便な検出法。
3. The simple method for detecting DNA according to claim 1 or 2, wherein the fluorescent substance showing affinity for DNA is an antibiotic, a dye for nuclear staining, or an anticancer drug.
JP2647791A 1990-11-30 1991-02-20 Simple method for detecting dna product amplified by polymerase chain reaction(pcr) Pending JPH04267895A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2647791A JPH04267895A (en) 1991-02-20 1991-02-20 Simple method for detecting dna product amplified by polymerase chain reaction(pcr)
EP91120311A EP0488243A1 (en) 1990-11-30 1991-11-27 Method of extracting virus genome from sample derived from living body infected with the virus and detecting the genome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2647791A JPH04267895A (en) 1991-02-20 1991-02-20 Simple method for detecting dna product amplified by polymerase chain reaction(pcr)

Publications (1)

Publication Number Publication Date
JPH04267895A true JPH04267895A (en) 1992-09-24

Family

ID=12194586

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2647791A Pending JPH04267895A (en) 1990-11-30 1991-02-20 Simple method for detecting dna product amplified by polymerase chain reaction(pcr)

Country Status (1)

Country Link
JP (1) JPH04267895A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63102677A (en) * 1986-08-22 1988-05-07 エフ.ホフマン―ラ ロシュ アクチェンゲゼルシャフト Heat stable enzyme and its use

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63102677A (en) * 1986-08-22 1988-05-07 エフ.ホフマン―ラ ロシュ アクチェンゲゼルシャフト Heat stable enzyme and its use

Similar Documents

Publication Publication Date Title
Maniatis et al. Chain length determination of small double-and single-stranded DNA molecules by polyacrylamide gel electrophoresis
Wang et al. Effects of anticoagulants and storage of blood samples on efficacy of the polymerase chain reaction assay for hepatitis C virus
EP0487218A1 (en) Method for detecting or quantifying target nucleic acid
Ferrante et al. PCR detection of JC virus DNA in brain tissue from patients with and without progressive multifocal leukoencephalopathy
NZ223700A (en) Method of assaying nucleic acids
US5059294A (en) Method for separating nucleic acids and nucleic acid probes
Satoh et al. Virus concentration using polyethyleneimine-conjugated magnetic beads for improving the sensitivity of nucleic acid amplification tests
ES2644949T3 (en) Oligonucleotides to control nucleic acid amplification
Toh et al. An integrated microsatellite length analysis using an automated fluorescent DNA sequencer
CN113684317A (en) Ultra-sensitive rapid detection and identification system for B type and C type hepatitis B virus based on CRISPR-Cas12B
JP4025833B2 (en) Gene analysis method, gene analysis kit and gene analysis apparatus used therefor
TW201215681A (en) Micro electrochemical multiplex real-time PCR system
Gu et al. Prevalence of BK virus and JC virus in peripheral blood leukocytes and normal arterial walls in healthy individuals in China
JPH04267895A (en) Simple method for detecting dna product amplified by polymerase chain reaction(pcr)
Sunzeri et al. Rapid simultaneous detection of multiple retroviral DNA sequences using the polymerase chain reaction and capillary DNA chromatography
Vary Triple-helical capture assay for quantification of polymerase chain reaction products
Skogerboe Molecular biology techniques
KR100845949B1 (en) An improved method for preparing DNA from serum and plasma
CN109266783B (en) Molecular beacon-G quadruplex optical sensor and application thereof in detection of SV40 virus
JP2718823B2 (en) Methods for evaluating the suitability of clinical samples for hybridization assays and evaluation kits
JPH0484751A (en) Gene detecting method
JPH0568596A (en) Detection of dna multiplied by polymerase chain reaction
Changotra et al. Quantitative detection of serum HBV DNA levels employing a new S gene based cPCR assay
Fox et al. Use of DNA amplification methods for clinical diagnosis in autoimmune diseases
WO2022015250A1 (en) Biomolecule locating device and the relevant method thereof